Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Study: Robotic arms reach to advance heart surgery

Researchers from the Montpellier Laboratory of Informatics, Robotics and Microelectronics in Montpellier Cedex, France, have developed the thin-plate spline deformable 3D computerized model that enables a robotic arm to operate on a beating heart during surgery, a study published Dec.15 in the International Journal of Robotics Research found.

Feature: Bhatt questions PCI volume as surrogate for hospital quality

In previous research, investigators have found a direct correlation between hospital primary angioplasty volume and mortality rates in STEMI patients, resulting in a volume criteria for provider settings. However, Deepak L. Bhatt, MD, told Cardiovascular Business News that based on the findings of a recent JAMA study, the volume surrogate should be reconsidered as basis for hospital quality.

Stentys trial to compare stent effectiveness in AMI patients

The APPOSITION II clinical study, designed to compare the effectiveness of the Stentys self-expanding stent and a conventional balloon-expandable stent in acute MI patients, has enrolled its first participant, according to medical device provider Stentys.

Study: Costs of diabetes care, number diagnosed could skyrocket by 2034

By 2034, the number of people diagnosed with diabetes is estimated to reach 44.1 million, while the costs associated with the disease could skyrocket to $336 billion from the current $113 billion, according to research published in the December issue of Diabetes Care.

JAMA: Higher volume PCI hospitals do not reduce hospital length of stay

Even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to registry findings published in the Nov. 25 issue of Journal of the American Medical Association.

Did FDA ignore COGENT to slap warning on clopidogrel/PPI interaction?

The FDA is requiring a labeling change to Sanofi-Aventis and Bristol-Myers Squibbs blockbuster anti-bloodclotting drug clopidogrel (Plavix) to indicate that it should not be used with AstraZenecas proton pump inhibitor (PPI) omeprazole (Prilosec/Prilosec OTC) and some other acid-reducing drugs.

Vascular Solutions unveils new catheter for coronary interventions

Vascular Solutions has launched its GuideLiner catheter to provide better guided admittance to distinct regions of the coronary and peripheral vasculature during the intubation period for coronary interventions.

AHA: New 'fast-tracked' guidelines update STEMI management, PCI treatments

Two sets of fast-tracked clinical guidelines, issued today at the AHA conference in Orlando, Fla., focus on a community-wide collaboration of emergency services for the management of STEMI patients and present new treatment options for PCI.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup